Effect of Nose Selection Using Rhnoscope on Epistaxis of Nasotracheal Intubation

July 24, 2022 updated by: yun jeong chae, Ajou University School of Medicine

The Effect of Suitable Nose Selection Using Rhinoscope on the Incidence and Severity of Epistaxis After Nasotracheal Intubation.

Rhinoscope is useful to exam intranasal structure. This information could be utilized to select more suitable nose for nasotracheal intubation. Nastoracheal intubation using more patent nose could be associated with decrease of the development of epistaxis which is most common complication in nasotracheal intubation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Anterior rhinoscopy using rhinoscope is a simple way to view the intranasal structure, which allows you to observe the nasal mucosa, the inferior nasal concha, and in some cases, the nasal concha. You can see the nasal septum, polyps, and intranasal malformations. In addition, even when there are no structural abnormalities in the nasal cavity, the wider nasal cavity can be intuitively identified. This information is expected to assist in the selection of nostrils. It has not yet been studied whether anesthesiologists select nasal cavity for nasotracheal intubation using prosthesis can affect the occurrence of epistaxis.

The purpose of this study is to determine whether the selection of a nostril for nasotracheal intubation by rhinoscope affects the incidence and severity of epistaxis.

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeong-gi Do
      • Suwon-si, Gyeong-gi Do, Korea, Republic of, 16499
        • Ajou universitiy school of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA I or II undergoing surgery under nasotracheal intubation

Exclusion Criteria:

  • expected difficult intubation based on history, physical examination, weight.
  • bleeding tendency
  • past history of nasal surgery
  • symptom of difficulty of nasal respiration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: control group
nose selection will be done by random table
EXPERIMENTAL: rhinoscope group
nose selection will be done by rhinoscopy
more suitable nose for nasotracheal intubation will be selected based on the view of rhinoscope.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of epistaxis
Time Frame: immediate after intubation
percentage of the development of epistaxis after nasotracheal intubation
immediate after intubation
incidence of epistaxis
Time Frame: 5 min after intubation
percentage of the development of epistaxis after nasotracheal intubation
5 min after intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
severity of epistaxis4. severe: interfere intubation by blood
Time Frame: immediate after intubation

score based on severity of epistaxis will be recorded.

1: no epistaxis, 2: mild; blood on tube 3. moderate: blood pooling on pharynx

immediate after intubation
severity of epistaxis
Time Frame: 5 min after intubation

score based on severity of epistaxis will be recorded.

1: no epistaxis, 2: mild; blood on tube 3. moderate: blood pooling on pharynx

5 min after intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: yun jeong chae, PhD MD, Ajou University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 26, 2019

Primary Completion (ACTUAL)

March 30, 2022

Study Completion (ACTUAL)

March 30, 2022

Study Registration Dates

First Submitted

November 12, 2019

First Submitted That Met QC Criteria

November 13, 2019

First Posted (ACTUAL)

November 15, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 24, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We will share data when reasonable personal request exist.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nasotracheal Intubation

3
Subscribe